Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses

Detalles Bibliográficos
Autores principales: Joseph, Jeswin, Karthika, T., Das, V.R. Akshay, Raj, V. Stalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158315/
https://www.ncbi.nlm.nih.gov/pubmed/34052520
http://dx.doi.org/10.1016/j.jgar.2021.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158315/
https://www.ncbi.nlm.nih.gov/pubmed/34052520
http://dx.doi.org/10.1016/j.jgar.2021.05.005

Ejemplares similares